Portugal: GreenBe Pharma obtains EuGMP certification at Elvas facilities

A GreenBe Pharma, a medicinal cannabis company located in Elvas, Portugal, has obtained EU-GMP certification, under the European Union's Good Manufacturing Practices regulations, the company announced in a press release. The first batches of EU-GMP compliant products will be available this spring, allowing GreenBe to process pharmaceutical-grade cannabis flowers for international markets. Compliance with EU GMP rules is mandatory for international trade and demonstrates that the company adheres to global pharmaceutical standards, making this certification an important milestone for GreenBe Pharma, which has around 10.000 m2 designed for growing cannabis plants , GreenBe Pharma uses high-tech greenhouses under energy-efficient processes and sustainable practices. The facilities have operated since their foundation under GACP Standards, Good Agricultural and Harvest Practices, which was also certified by Infarmed, in September 2023. At its Elvas unit, GreenBe includes 19 independent cultivation chambers, each with its own climate control capabilities. Furthermore, the processing facility that has achieved EU-GMP certification will enable a maximum processing capacity of up to four tonnes of dried cannabis flowers annually in the form of Active Pharmaceutical Ingredients (API) to serve national and international markets. The company also announced that it has developed and is currently fulfilling cultivation and manufacturing agreements with pharmaceutical and distribution companies to distribute its medical cannabis products in Portugal, Germany, the United Kingdom, Australia and other international markets, ensuring patient access to prescriptions in pharmacies. This achievement represents a significant milestone for GreenBe Pharma, as these are currently some of the fastest growing markets for medical cannabis globally. Over the past 18 months, GreenBe has invested in its cultivation and manufacturing capabilities to ensure that its products meet the quality requirements of its partners and meet the strictest standards of international regulations. João Janeiro, operations director at GreenBe Pharma, stated that “achieving this important milestone for us was possible thanks to the efforts of the company that provides the means and resources to build the most efficient and robust medical cannabis production system in Portugal”. At GreenBe Pharma there is a clear vocation for highly efficient agricultural production, right from the project's conception. “We have been growing other valuable crops for six generations and we will focus on what we are good at: growing the highest quality plants, from the best breeding programs in the world, that the patient-oriented market demands,” said João Janeiro. Eliecer Lopez, business development manager at GreenBe Pharma, said that “after the entire complex was built and operational in just 11 months, obtaining Infarmed accreditation for EU-GMP has been one of the most challenging parts of the entire project. process. However, the time since construction has allowed us to test and select a wide range of genetics for different purposes and to test and fine-tune state-of-the-art facilities to achieve operational excellence.” The customer-focused strategy, according to the company, aims to provide innovative products to patients around the world. GreenBe Pharma has designed a portfolio of cultivars to combine higher THC products with popular varieties balanced with exceptional terpenoid profiles. “The production and quality assurance team have done an excellent job, ensuring that any flower harvested and processed at our Elvas facility since July 2023, with passion and attention to detail, will comply with EU GMP standards.

____________________________________________________________________________________________________

____________________________________________________________________________________________________

What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!

Laura Ramos

More postsBiography

With a degree in Journalism from the University of Coimbra, Laura Ramos has a postgraduate degree in Photography and has been a Journalist since 1998. Winner of the Business of Cannabis Awards in the category "Journalist of the Year 2024", Laura was a correspondent for Jornal de Notícias in Rome, Italy, and Press Officer in the Office of the Minister of Education of the 2018st Portuguese Government. She has an international certification in Permaculture (PDC) and created the street-art photography archive “What does Lisbon say?” @saywhatlisbon. Co-founder and Editor of CannaReporter® and coordinator of PTMC - Portugal Medical Cannabis, Laura made the documentary “Pacientes” in XNUMX and was part of the steering group of the first Postgraduate Course in GxP's for Medicinal Cannabis in Portugal, in partnership with the Military Laboratory and the Faculty of Pharmacy of the University of Lisbon.

• Laura Ramos

  https://cannareporter.eu/author/partner/

  Brazil: São Paulo hosts 4th edition of Medical Cannabis Fair from May 22nd to 24th
• Laura Ramos

  https://cannareporter.eu/author/partner/

  Jürgen Bickel: “I would like to see more respect for recreational users, because at least half of them are also medicinal users”
• Laura Ramos

  https://cannareporter.eu/author/partner/

  SENSIHEMP wins excellence award at CSFW in Madrid with collection made 100% from hemp
• Laura Ramos

  https://cannareporter.eu/author/partner/

  'Pepe' Mujica, former president of Uruguay and the first in the world to fully legalize cannabis, has died